Y-90-Tabituximab barzuxetan
90Y-Tabituximab barzuxetan (90Y-OTSA101-DTPA) is a radiolabeled drug based on an [...]
90Y-Tabituximab barzuxetan (90Y-OTSA101-DTPA) is a radiolabeled drug based on an [...]
90Y-FAPi-04 is the therapeutic analogue of the PET imaging agent [...]
90Y-BetaGlue is an original product described as a medical device [...]
90Y-Anditixafortide (90Y-Pentixather) is the therapeutic analogue of 68Ga-Pentixafor, to be [...]
90Y-Ibritumomab tiuxetan (Zevalin®) is an IgG1 kappa-monoclonal murine antibody directed [...]
90Y-Yttrium Citrate as a colloidal suspension is used for therapeutic [...]
Ferritarg is a rabbit polyclonal antibody that is coupled with [...]
90Y-Epratuzumab tetraxetan entered the clinical phase as early as 1996. [...]
90Y-labeled humanized anti-Tac (90Y-HAT, 90Y-Daclizumab) is a radiolabeled monoclonal antibody [...]
90Y-OPS201 (90Y-DOTA-JR11, 90Y-SOMTher®) is a proprietary drug that specifically binds [...]